Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson Disease With Orthostatic Hypotension”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Large-scale testing (Phase 3)Study completedNCT05487300
What this trial is testing

Effect of Levodopa on Cardiovascular Autonomic Function in Parkinson's Disease

Who this might be right for
Parkinson DiseaseOrthostatic Hypotension
University of Utah 40
Large-scale testing (Phase 3)Ended earlyNCT04095793
What this trial is testing

Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 110
Large-scale testing (Phase 3)Study completedNCT00738062
What this trial is testing

Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Neurogenic Orthostatic HypotensionNon-Diabetic Autonomic NeuropathyMultiple System Atrophy+1 more
Chelsea Therapeutics 103
Testing effectiveness (Phase 2)Study completedNCT02705755
What this trial is testing

TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)

Who this might be right for
Neurogenic Orthostatic HypotensionMultiple System Atrophy (MSA) With Orthostatic HypotensionPure Autonomic Failure+5 more
Theravance Biopharma 34
Post-approval studies (Phase 4)Study completedNCT04510922
What this trial is testing

Lundbeck TOMs Orthostatic Hypotension

Who this might be right for
Orthostatic HypotensionIdiopathic Parkinson Disease
Alberto Espay, MD, MSc 9
Large-scale testing (Phase 3)Ended earlyNCT01927055
What this trial is testing

A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionParkinson's DiseaseMultiple Systems Atrophy+2 more
Chelsea Therapeutics 61
Post-approval studies (Phase 4)Study completedNCT03229174
What this trial is testing

Brain Perfusion & Oxygenation in Parkinson's Disease With NOH

Who this might be right for
Parkinson DiseaseNeurogenic Orthostatic Hypotension
William Ondo, MD 17
Not applicableUnknownNCT03343574
What this trial is testing

Cardiovascular Effects of Exercise in Patients With Parkinson's Disease

Who this might be right for
Parkinson DiseaseOrthostatic Hypotension
Faizan Ahmed 300
Large-scale testing (Phase 3)Study completedNCT00633880
What this trial is testing

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic NeuropathyPrimary Autonomic Failure+1 more
Chelsea Therapeutics 181
Large-scale testing (Phase 3)Study completedNCT00782340
What this trial is testing

A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic NeuropathyPrimary Autonomic Failure+1 more
Chelsea Therapeutics 263
Large-scale testing (Phase 3)Study completedNCT03750552
What this trial is testing

Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 195
Testing effectiveness (Phase 2)UnknownNCT03567447
What this trial is testing

Effect of L-Dihydroxyphenylserine (L-DOPS) on Falls in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Parkinson DiseaseFalls Patient
St. Joseph's Hospital and Medical Center, Phoenix 10
Not applicableLooking for participantsNCT01799915
What this trial is testing

Natural History Study of Synucleinopathies

Who this might be right for
Patients With SynucleinopathiesNeurogenic Orthostatic HypotensionPure Autonomic Failure+5 more
NYU Langone Health 800
Post-approval studies (Phase 4)Study completedNCT02586623
What this trial is testing

Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
H. Lundbeck A/S 453
Testing effectiveness (Phase 2)UnknownNCT00758849
What this trial is testing

Fipamezole in Neurogenic Orthostatic Hypotension

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Parkinson's DiseaseMultiple System Atrophy
Juvantia Pharma Ltd 24
Not applicableNot Yet RecruitingNCT07139756
What this trial is testing

Deciphering the Mechanisms of Central BP Regulation in Patients With PD Associated With Orthostatic Hypotension

Who this might be right for
Parkinson DiseaseOrthostatic Hypotension
Centre Hospitalier Universitaire Vaudois 130
Large-scale testing (Phase 3)Ended earlyNCT03829657
What this trial is testing

Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionMSAParkinson's Disease (PD)+1 more
Theravance Biopharma 203
Not applicableLooking for participantsNCT06838637
What this trial is testing

Transcutaneous Spinal Cord Stimulation Home Study

Who this might be right for
Spinal Cord InjuriesMultiple System Atrophy, Parkinson Variant
Michael Berger 6
Large-scale testing (Phase 3)Study completedNCT01176240
What this trial is testing

A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease

Who this might be right for
Orthostatic HypotensionParkinson's Disease
Chelsea Therapeutics 225
Very early researchStudy completedNCT04616456
What this trial is testing

Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients

Who this might be right for
Multiple System AtrophyMultiple System Atrophy, Cerebellar VariantMultiple System Atrophy, Parkinson Variant (Disorder)+1 more
Brigham and Women's Hospital 19
Load More Results